Claire Thomson
Papers
1
Total Citations
18
H-Index
1
About
Dr. Claire Thomson is a pioneering surgical oncologist whose research centers on molecularly targeted intraoperative imaging for prostate cancer. Her most notable contribution is the first-in-human study of the PSMA Minibody IR800-IAB2M, a novel fluorescent agent designed to provide real-time, molecularly guided visualization of prostate cancer during robot-assisted laparoscopic radical prostatectomy. This landmark 2024 study, which has already garnered 18 citations, demonstrated the feasibility of using a humanized PSMA minibody conjugated to IRDye 800CW to enhance surgical precision by illuminating malignant tissue that might otherwise be missed. Dr. Thomson’s work bridges the critical gap between preoperative imaging and intraoperative decision-making, potentially reducing positive surgical margins and improving oncologic outcomes. By translating advanced molecular imaging agents from bench to bedside, she is establishing a new paradigm for fluorescence-guided surgery in urologic oncology. Her research not only advances the field of image-guided surgery but also holds promise for improving the lives of men undergoing radical prostatectomy through more complete tumor resection.
Research Focus
Key Achievements
Top Papers
- 1